These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron. Hardick J; Gallagher N; Sachithanandham J; Fall A; Siddiqui Z; Pekosz A; Manabe YC; Mostafa HH Microbiol Spectr; 2022 Jun; 10(3):e0102522. PubMed ID: 35616382 [TBL] [Abstract][Full Text] [Related]
5. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer. LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036 [TBL] [Abstract][Full Text] [Related]
6. The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays. Anderson M; Holzmayer V; Harris B; Hodges A; Olivo A; Fortney T; Goldstein Y; Hirschhorn J; Pytel D; Faron ML; Cloherty G; Rodgers MA J Clin Virol; 2023 Sep; 166():105532. PubMed ID: 37459763 [TBL] [Abstract][Full Text] [Related]
8. The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid. Van Slambrouck J; Schoenaers C; Laenen L; Jin X; Beuselinck K; Verdonck A; Wauters J; Molenberghs G; Vanaudenaerde BM; Vos R; Mombaerts P; Lagrou K; Ceulemans LJ J Virol Methods; 2024 Jan; 323():114848. PubMed ID: 37944670 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19). Nicholson BD; Turner PJ; Fanshawe TR; Williams AJ; Amirthalingam G; Tonner S; Zambon M; Body R; Davies K; Perera R; de Lusignan S; Hayward GN; Hobbs FDR; PLoS One; 2023; 18(7):e0288612. PubMed ID: 37478103 [TBL] [Abstract][Full Text] [Related]
10. A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19. Golden A; Cantera JL; Lillis L; Phan TT; Slater H; Webb EJ; Peck RB; Boyle DS; Domingo GJ Microbiol Spectr; 2023 Jun; 11(3):e0373122. PubMed ID: 37166329 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance. Tan CY; Zeng K; Cui L; Lin RTP; Chen M BMC Infect Dis; 2024 May; 24(1):504. PubMed ID: 38769524 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens. Galliez RM; Bomfim L; Mariani D; Leitão IC; Castiñeiras ACP; Gonçalves CCA; Ortiz da Silva B; Cardoso PH; Arruda MB; Alvarez P; Brindeiro R; Ota VA; Rodrigues DGM; da Costa LJ; Ferreira ODC; Castiñeiras TMPP; Faffe DS; Tanuri A Microbiol Spectr; 2022 Jun; 10(3):e0125022. PubMed ID: 35652635 [TBL] [Abstract][Full Text] [Related]
13. Development and Clinical Performance of InteliSwab Fischl MJ; Young J; Kardos K; Roehler M; Miller T; Wooten M; Holmes N; Gula N; Baglivo M; Steen J; Zelenz N; Joyee AG; Munster V; Weishampel Z; Yinda CK; Rouse KG; Gvozden C; Wever D; Yanez G; Anderson M; Yu S; Bearie B; Young S; Berry JD Viruses; 2023 Dec; 16(1):. PubMed ID: 38257761 [TBL] [Abstract][Full Text] [Related]
14. Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages. Osterman A; Krenn F; Iglhaut M; Badell I; Lehner A; Späth PM; Stern M; Both H; Bender S; Muenchhoff M; Graf A; Krebs S; Blum H; Grimmer T; Durner J; Czibere L; Dächert C; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT Med Microbiol Immunol; 2023 Oct; 212(5):307-322. PubMed ID: 37561226 [TBL] [Abstract][Full Text] [Related]
15. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ; Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452 [TBL] [Abstract][Full Text] [Related]
16. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant. Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Abbott Panbio Shaw JLV; Deslandes V; Smith J; Desjardins M Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115514. PubMed ID: 34418823 [TBL] [Abstract][Full Text] [Related]
18. Performance Evaluation of Five Rapid At-Home COVID-19 Antigen Tests against the Omicron Variant. Sugiharto VA; Gatrell SK; Chen HW; Blazek GR; Cherry AM; Schilling M Microbiol Spectr; 2023 Feb; 11(1):e0228622. PubMed ID: 36519888 [TBL] [Abstract][Full Text] [Related]
19. Investigating the Sensitivity of Nasal or Throat Swabs: Combination of Both Swabs Increases the Sensitivity of SARS-CoV-2 Rapid Antigen Tests. Goodall BL; LeBlanc JJ; Hatchette TF; Barrett L; Patriquin G Microbiol Spectr; 2022 Aug; 10(4):e0021722. PubMed ID: 35762772 [TBL] [Abstract][Full Text] [Related]
20. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19. Stokes W; Berenger BM; Portnoy D; Scott B; Szelewicki J; Singh T; Venner AA; Turnbull L; Pabbaraju K; Shokoples S; Wong AA; Gill K; Guttridge T; Proctor D; Hu J; Tipples G Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1721-1726. PubMed ID: 33742322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]